Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in the Perioperative Care of Liver Transplant Recipients: A Single Center Experience

Therapeutic Apheresis and Dialysis

Volumn 19, Issue 1, 2015, Pages 8-15

  Sponholz, Christoph ^a   Settmacher, Utz ^a   Bauer, Michael ^a,b   Kortgen, Andreas ^a,b  

^a Department of Anaesthesiology and Critical Care Medicine Visceral and Vascular Surgery   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Acid base status; Citrate anticoagulation; Electrolyte balance; Hemodialysis; Intensive care; Liver failure

Indexed keywords

BICARBONATE; CITRIC ACID; LACTIC ACID; ANTICOAGULANT AGENT;

ACID BASE BALANCE; ADULT; ALKALOSIS; ANTICOAGULATION; ARTICLE; CONTINUOUS HEMODIALYSIS; CONTROLLED STUDY; ELECTROLYTE BALANCE; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS; HUMAN; HYPERNATREMIA; HYPOCALCEMIA; INTENSIVE CARE UNIT; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; LIVER DYSFUNCTION; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; PH; PRIORITY JOURNAL; REGIONAL CITRATE ANTICOAGULATION; RETROSPECTIVE STUDY; SEVERE HEPATIC IMPAIRMENT; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; COHORT ANALYSIS; EVALUATION STUDY; GRAFT REJECTION; GRAFT SURVIVAL; KIDNEY FUNCTION TEST; LIVER FAILURE; LIVER TRANSPLANTATION; NONPARAMETRIC TEST; PROCEDURES; PROGNOSIS; RENAL REPLACEMENT THERAPY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ACID-BASE EQUILIBRIUM; ACUTE KIDNEY INJURY; ANTICOAGULANTS; CITRIC ACID; COHORT STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; KIDNEY FUNCTION TESTS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84922737784     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12196     Document Type: Article

References (17)

1. Weber ML, Ibrahim HN, Lake JR. Renal dysfunction in liver transplant recipients: evaluation of the critical issues. Liver Transpl 2012;18:1290-1301.
2. Hetzel GR, Schmitz M, Wissing H etal. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011;26:232-239.
3. Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy-heparin or citrate? Crit Care 2011;15:202.
4. Schultheiss C, Saugel B, Phillip V etal. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care 2012;16:R162.
5. Saner FH, Treckmann JW, Geis A etal. Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy. Nephrol Dial Transplant 2012;27:1651-1657.
6. Link A, Klingele M, Speer T etal. Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients. Crit Care 2012;16:R97.
7. Tolwani AJ, Wille KM. Anticoagulation for continuous renal replacement therapy. Semin Dial 2009;22:141-145.
8. Morgera S, Scholle C, Voss G etal. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clin Pract 2004;97:c131-136.
9. Kalb R, Kram R, Morgera S, Slowinski T, Kindgen-Milles D. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk. Ther Apher Dial 2013;17:202-212.
10. Finkel KW, Podoll AS. Complications of continuous renal replacement therapy. Semin Dial 2009;22:155-159.
11. Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voort PH. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clin Chem Lab Med 2006;44:962-966.
12. Balogun RA, Turgut F, Caldwell S, Abdel-Rahman EM. Regional citrate anticoagulation in critically ill patients with liver and kidney failure. J Nephrol 2012;25:113-119.
13. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001;29:748-752.
14. Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 2012;38:20-28.
15. Sakr Y, Rother S, Ferreira AM etal. Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients. Crit Care Med 2013;41:133-142.
16. Bengus A, Babiuc RD. Hyponatremia-predictor of adverse prognosis in cirrhosis. J Med Life 2012;5:176-178.
17. Morgera S, Schneider M, Slowinski T etal. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 2009;37:2018-2024.